Linagliptin-related pancreatitis in a diabetic patient with biliary calculus A case report


Creative Commons License

ÖZKAN SEVENCAN N. , Ozkan A. E. , KAYHAN B.

MEDICINE, cilt.97, 2018 (SCI İndekslerine Giren Dergi) identifier identifier identifier

Özet

Rationale: Dipeptidyl peptidase-4 inhibitors are commonly used drugs for the treatment of type 2 diabetes mellitus. While acute pancreatitis cases induced by saxagliptin, sitagliptin, and vildagliptin (all of which are members of the dipeptidyl peptidase-4 group) have been reported, there is no clear evidence suggesting that linagliptin may cause pancreatitis, and information in this regard is limited to a few studies. Moreover, no pancreatitis cases have been reported that were directly associated with linagliptin.